Broad Institute, Dana-Farber, and Count Me In receive $16 million to launch patient-partnered research initiatives in rare cancers

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, and Count Me In, a non-profit research initiative that conducts patient-partnered studies of cancer, were awarded a $16 million grant from NCI to accelerate research in two rare forms of cancer.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login